Janssen-Cilag International
34 products tracked · names used in filings: Janssen-Cilag International, Janssen Cilag International NV, Janssen-Cilag International NV
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 18 Sep 2026🇪🇺 EU approval (EC decision)
Icotyde (icotrokinra hydrochloride) approved in the EU
Marketing authorisation to Janssen-Cilag International; Additional monitoring · source
Thu 23 Jul 2026🇪🇺 CHMP positive opinion
Icotyde (icotrokinra hydrochloride): CHMP positive opinion
Janssen-Cilag International; Additional monitoring · source
Fri 28 Nov 2025🇪🇺 EU approval (EC decision)
Imaavy (nipocalimab) approved in the EU
Marketing authorisation to Janssen Cilag International NV; Additional monitoring · source
Mon 03 Nov 2025🇪🇺 CHMP positive opinion
Imaavy (nipocalimab): CHMP positive opinion
Janssen Cilag International NV; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Plivensia sirukumab | Application withdrawn | |
| 🇪🇺 | Comfyde carisbamate | Application withdrawn | |
| 🇪🇺 | Zeftera (previously Zevtera) ceftobiprole | Refused | |
| 🇪🇺 | Icotyde icotrokinra hydrochloride | Authorised | 2026-09-18 |
| 🇪🇺 | Imaavy nipocalimab | Authorised | 2025-11-28 |
| 🇪🇺 | Lazcluze lazertinib | Authorised | 2025-01-20 |
| 🇪🇺 | Yuvanci macitentan;tadalafil | Authorised | 2024-09-27 |
| 🇪🇺 | Carvykti ciltacabtagene autoleucel | Authorised | 2022-05-25 |
| 🇪🇺 | Jcovden (previously COVID-19 Vaccine Janssen) COVID-19 vaccine (Ad26.COV2-S [recombinant]) | Withdrawn | 2021-03-11 |
| 🇪🇺 | Rekambys rilpivirine | Authorised | 2020-12-17 |
| 🇪🇺 | Spravato esketamine | Authorised | 2019-12-18 |
| 🇪🇺 | Erleada apalutamide | Authorised | 2019-01-14 |
| 🇪🇺 | Tremfya guselkumab | Authorised | 2017-11-10 |
| 🇪🇺 | Symtuza darunavir;cobicistat;emtricitabine;tenofovir alafenamide | Authorised | 2017-09-21 |
| 🇪🇺 | Uptravi selexipag | Authorised | 2016-05-12 |
| 🇪🇺 | Trevicta (previously Paliperidone Janssen) paliperidone | Authorised | 2014-12-05 |
| 🇪🇺 | Imbruvica ibrutinib | Authorised | 2014-10-21 |
| 🇪🇺 | Olysio simeprevir | Withdrawn | 2014-05-14 |
| 🇪🇺 | Vokanamet canagliflozin;metformin | Authorised | 2014-04-23 |
| 🇪🇺 | Invokana canagliflozin | Authorised | 2013-11-15 |
| 🇪🇺 | Stayveer bosentan monohydrate | Authorised | 2013-06-24 |
| 🇪🇺 | Incivo telaprevir | Expired | 2011-09-19 |
| 🇪🇺 | Zytiga abiraterone | Authorised | 2011-09-05 |
| 🇪🇺 | Xeplion paliperidone | Authorised | 2011-03-04 |
| 🇪🇺 | Simponi golimumab | Authorised | 2009-10-01 |
| 🇪🇺 | Stelara ustekinumab | Authorised | 2009-01-16 |
| 🇪🇺 | Intelence etravirine | Authorised | 2008-08-28 |
| 🇪🇺 | Doribax doripenem | Withdrawn | 2008-07-25 |
| 🇪🇺 | Invega paliperidone | Authorised | 2007-06-24 |
| 🇪🇺 | Prezista darunavir | Authorised | 2007-02-11 |
| 🇪🇺 | Ionsys fentanyl | Withdrawn | 2006-01-24 |
| 🇪🇺 | Velcade bortezomib | Authorised | 2004-04-26 |
| 🇪🇺 | Remicade infliximab | Authorised | 1999-08-13 |
| 🇪🇺 | Regranex becaplermin | Withdrawn | 1999-03-29 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.